MISSISSAUGA, ONTARIO--(MARKET WIRE)--Aug 16, 2007 -- Covalon Technologies Ltd. (the “Corporation” or “Covalon”) (CDNX:COV.V - News) announced a significant development by producing a covalently-bonded, silver-ion releasing antimicrobial and low-blood-clotting coating that can be applied to a wide variety of blood-contacting catheters and devices in order to minimize potential for blood-clot formation.
